Suppr超能文献

肾移植后肝紫癜合并门静脉高压症

Peliosis hepatis complicated by portal hypertension following renal transplantation.

作者信息

Demyashkin Grigory, Zatsepina Margarita

机构信息

Department of Pathology, Sechenov University, Moscow 119146, Russia.

出版信息

World J Gastroenterol. 2020 Sep 14;26(34):5220-5222. doi: 10.3748/wjg.v26.i34.5220.

Abstract

Peliosis hepatis is a rare benign disease, but in last years the number of identified cases has increased. This disease is known to be sometimes accompanied by hepatocellular carcinoma. In the recent article, Yu et al describe a case of liver peliosis, characterized by an increased proliferative index. Therefore, additional diagnosis of patients should include analyzing other tumor markers expression in order to assess the risk of malignant cell transformation in peliosis hepatis.

摘要

肝紫癜是一种罕见的良性疾病,但近年来确诊病例数有所增加。已知这种疾病有时会伴有肝细胞癌。在最近的一篇文章中,Yu等人描述了一例肝紫癜病例,其特征是增殖指数升高。因此,对患者的进一步诊断应包括分析其他肿瘤标志物的表达,以评估肝紫癜中恶性细胞转化的风险。

相似文献

1
Peliosis hepatis complicated by portal hypertension following renal transplantation.
World J Gastroenterol. 2020 Sep 14;26(34):5220-5222. doi: 10.3748/wjg.v26.i34.5220.
2
Peliosis hepatis complicated by portal hypertension following renal transplantation.
World J Gastroenterol. 2014 Mar 7;20(9):2420-5. doi: 10.3748/wjg.v20.i9.2420.
5
Peliosis hepatis as an early histological finding in idiopathic portal hypertension: A case report.
World J Gastroenterol. 2006 Jun 14;12(22):3612-5. doi: 10.3748/wjg.v12.i22.3612.
6
Peliosis Hepatis Mimicking Malignant Hypervascular Tumors.
J Gastrointest Surg. 2017 Jun;21(6):1095-1098. doi: 10.1007/s11605-016-3298-5. Epub 2016 Oct 25.
7
Peliosis hepatis in a living related liver transplantation donor candidate.
J Gastroenterol Hepatol. 2006 Jun;21(6):1075-7. doi: 10.1111/j.1440-1746.2006.03172.x.
9
Peliosis hepatis and systemic lupus erythematosus: A rare condition identified by magnetic resonance imaging.
Rev Assoc Med Bras (1992). 2018 Jan;64(1):19-21. doi: 10.1590/1806-9282.64.01.19.

本文引用的文献

1
Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis.
J Clin Med. 2019 May 10;8(5):646. doi: 10.3390/jcm8050646.
2
E-cadherin: Its dysregulation in carcinogenesis and clinical implications.
Crit Rev Oncol Hematol. 2018 Jan;121:11-22. doi: 10.1016/j.critrevonc.2017.11.010. Epub 2017 Nov 20.
3
Surveillance in cholangiocellular carcinoma.
Best Pract Res Clin Gastroenterol. 2016 Dec;30(6):987-999. doi: 10.1016/j.bpg.2016.11.001. Epub 2016 Nov 14.
4
Survivin in survival of hepatocellular carcinoma.
Cancer Lett. 2016 Sep 1;379(2):184-90. doi: 10.1016/j.canlet.2015.06.016. Epub 2015 Jun 25.
5
β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.
Cancer Res. 2014 Aug 15;74(16):4515-25. doi: 10.1158/0008-5472.CAN-13-3275. Epub 2014 May 21.
6
Peliosis hepatis complicated by portal hypertension following renal transplantation.
World J Gastroenterol. 2014 Mar 7;20(9):2420-5. doi: 10.3748/wjg.v20.i9.2420.
7
Liver failure due to hepatic angiosarcoma in an adolescent with dyskeratosis congenita.
J Pediatr Hematol Oncol. 2014 May;36(4):312-5. doi: 10.1097/MPH.0b013e318286d4d4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验